Warning Letter — Mineral BioSciences, LLC
The FDA issued a Warning Letter to Mineral BioSciences, LLC on June 5, 2026, following an evaluation by the Human Foods Program.
This action affects Mineral BioSciences, LLC and potentially involves personnel responsible for food safety, quality control, and regulatory labeling within the organization.
The issuance of a Warning Letter by the Human Foods Program indicates significant regulatory deviations that the FDA deems necessary to address to maintain compliance. While the source provided is a summary and does not detail specific violations, such letters typically signify issues with Good Manufacturing Practices (GMP), labeling, or unapproved claims. Failure to remediate these issues can lead to further enforcement actions, including seizure or injunction.
Verify that all product claims and manufacturing processes align with Human Foods Program requirements. Regulatory and QA teams should conduct an internal audit of labeling and production documentation to ensure compliance with the specific standards cited in the Warning Letter.
FDA Warning Letter issued to: Mineral BioSciences, LLC. 06/05/2026 — Human Foods Program. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mineral-biosciences-llc-724745-06052026
Open in openFDA / FDA.gov